Real-time enrollment status for this relapsing remitting multiple sclerosis clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:37 AM UTC
| NCT Number | NCT05949580 |
| Recruiting Status | Recruiting |
| Condition | Relapsing Remitting Multiple Sclerosis |
| Phase | Clinical Trial |
| Target Enrollment | 500 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Hoffmann-La Roche |
| Last Updated on CT.gov | January 20, 2026 (Jan 20, 2026) |
As of July 13, 2026: Clinical trial NCT05949580 is currently recruiting participants. This clinical trial study for relapsing remitting multiple sclerosis is actively seeking new participants at 3 locations across the United States. The study is sponsored by Hoffmann-La Roche. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05949580 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05949580 was last updated Jan 20, 2026 (January 20, 2026). HelloStudys verifies this status automatically.